All News

Found 318 articles

• Genmab A/S Announces FDA Approval Of DARZALEX (Daratumumab) For Multiple Myeloma And Updates Financial Guidance

  11/17/2015

• Genmab A/S Release: Data Published In The New England Journal of Medicine Shows Daratumumab Monotherapy Induced Durable Responses In Heavily Pre-Treated Relapsed Or Refractory Multiple Myeloma Patients

  8/27/2015

• Genmab A/S Announces Completion Of Rolling Submission Of Biologics License Application For Daratumumab In Multiple Myeloma And Achievement Of A USD 15 Million Milestone

  7/10/2015

• Genmab A/S Announces Start Of Rolling Submission Of Biologics License Application For Daratumumab For Double Refractory Multiple Myeloma To The FDA

  6/8/2015

• Inovio Pharmaceuticals Selected By Defense Advanced Research Projects Agency To Lead A $45 Million Program To Expedite Development Of Novel Products To Prevent And Treat Disease Caused By Ebola

  4/8/2015

• Celltrion, Inc. Launches World’s First Biosimilar Monoclonal Antibody Remsima In 12 New European Markets

  2/25/2015

• Hospira Launches First Biosimilar Monoclonal Antibody (mAb) Inflectra (Infliximab) In Major European Markets

  2/16/2015

• Janssen Research & Development To Demonstrate Breadth Of Oncology Portfolio With 42 Clinical Data Presentations At The 2014 American Society of Hematology Annual Meeting

  11/6/2014

• Immunomedics, Inc. Publishes Results On Immunotherapy Of Solid Cancers Mediated By A Novel Bispecific Antibody

  9/26/2014

• Using Tobacco To Thwart Infectious Disease? Arizona State University Study

  3/28/2014

• Janssen Research & Development Oncology Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, Including ZYTIGA®, Ibrutinib and Daratumumab Data

  5/16/2013

• Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at American Society of Hematology Responses Significantly Correlated to Overall Survival Summary: Three ofatumumab Abstracts Have Been Accepted for Presentation at the ASH Meeting December 6-9, 2008

  11/10/2008

• Genmab A/S to Present Zanolimumab and Ofatumumab Data at ASH Summary

  11/9/2007

• ImClone Systems Incorporated And Bristol-Myers Squibb Announce Application In Japan For Use Of ERBITUX In Metastatic Colorectal Cancer

  2/5/2007

• Human Genome Sciences, Inc. Reports Results Of Phase 2 Clinical Trial Of HGS-ETR1 In Patients With Advanced Non-Hodgkin's Lymphoma

  12/12/2005

• Human Genome Sciences, Inc. Reports Interim Results Of Phase 1b Clinical Trials Of HGS-ETR1 In Combination With Chemotherapy In Patients With Advanced Solid Tumors

  11/17/2005

• Human Genome Sciences, Inc. Reports Results Of Phase 1 Clinical Trials Of HGS-ETR2 In Patients With Advanced Solid Tumors

  11/17/2005

• Human Genome Sciences, Inc. Reports Results Of Phase 2 Clinical Trial Of HGS-ETR1 In Patients With Advanced Colorectal Cancer

  11/1/2005